Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Adageis Offers Easy-to-Use AI-Driven Solution to Help Healthcare Providers Unlock High-Value Care, Maximize Revenue

For healthcare practices navigating the shift toward value-based care, the complexity of insurance contracts, quality metrics, and data reporting can be a barrier to better outcomes and stronger financial performance. Adageis, a growing healthcare technology company, is offering a unique streamlined and AI-powered software solution designed to make this transition simpler. At the core of […]

FAVO Capital Inc. (FAVO) Delivering Funding Solutions in Private Credit Market, Poised for Significant Growth

The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized businesses (“SMBs”) (https://ibn.fm/pDNA4). This confluence of factors is reshaping the financial landscape, as companies such […]

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Discusses Business Model, Competitive Advantage During GotStocks Podcast

Disseminated on behalf of SolarBank Corporation Dr. Richard Lu, CEO of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., offered insights into the company’s operations, strategy, and unique competitive position during a […]

Siyata Mobile Inc. (NASDAQ: SYTA) Is ‘One to Watch’ 

Siyata Mobile Inc. (NASDAQ: SYTA) is a technology company providing advanced communication solutions for frontline workers, emergency responders, and mobile workforces. Its core offerings include the SD7 push-to-talk handset and Uniden(R)-branded signal boosters, both designed to improve operational connectivity where traditional networks fall short. These products are FCC- and IC-certified and distributed through Tier-1 carriers, […]

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is expanding its international footprint by launching localized websites in Arabic, Italian, and Spanish. The initiative is part of the firm’s strategy to boost commercial activity across high-potential regions with growing demand for workplace safety and compliance solutions (https://ibn.fm/odRAg). The […]

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders, particularly suicidal depression and PTSD. The company is leveraging its patented NMDA receptor modulation platform with two drugs, NRX-100 (preservative-free ketamine) and NRX-101 (D-cycloserine/lurasidone), that have received FDA Fast Track and Breakthrough Therapy designations, respectively. Both address acute unmet medical […]

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform 

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of Republican lawmakers advocating for the therapeutic use of psychedelics to treat PTSD, depression, and suicidality among veterans—a movement recently spotlighted by The Wall Street Journal. After undergoing ibogaine and DMT therapy in Mexico in 2018, Luttrell described the experience as […]

Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases, recently announced its financial results for the first quarter of 2025, alongside a summary of the company’s latest accomplishments (https://ibn.fm/OMQmM). These milestones are representative of Soligenix’s continued commitment to advance its pipeline of therapeutic candidates, focusing on areas with significant […]

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO

Effective leadership is a cornerstone of organizational success, particularly in the dynamic and high-stakes realm of biotechnology. Recognizing the pivotal role of seasoned leadership, Calidi Biotherapeutics (NYSE American: CLDI) has announced the appointment of Eric Poma, PhD, as its new Chief Executive Officer and member of the board of directors (https://ibn.fm/qMEu4). This strategic transition underscores Calidi’s […]

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself for Growth Amid Palladium Market Dynamics

As the global economy continues to evolve and diversify, investors are seeking opportunities in sectors with long-term growth potential and strong fundamentals. Precious metals, long viewed as stores of value and industrial cornerstones, are receiving renewed attention, particularly palladium. With its essential role in automotive, industrial and emerging technology applications, palladium is poised to remain […]

 

From Our Blog

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

June 24, 2026

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has announced new in vitro proof-of-concept data supporting its BiTAC-ADC platform, a technology designed to improve the selectivity of antibody-drug conjugates in cancer treatment. The announcement comes as the company prepares to engage with potential pharmaceutical and biotechnology partners during the BIO International […]

Rotate your device 90° to view site.